{"id":66134,"date":"2023-02-10T15:47:03","date_gmt":"2023-02-10T13:47:03","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=66134"},"modified":"2023-10-09T10:42:05","modified_gmt":"2023-10-09T10:42:05","slug":"noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/","title":{"rendered":"Noves formacions en l’actuaci\u00f3 farmac\u00e8utica en pacients amb nutrici\u00f3 artificial"},"content":{"rendered":"\n

A finals de gener, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB)<\/strong> va organitzar la XVII edici\u00f3<\/strong> de la formaci\u00f3 \u201cActuaci\u00f3 farmac\u00e8utica en la nutrici\u00f3 artificial\u201d<\/strong>, conjuntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica<\/strong> (SCFC)<\/strong><\/a>, la coordinaci\u00f3 del Grup de Nutrici\u00f3 de Farmac\u00e8utics d\u2019Hospitals de Catalunya<\/strong><\/a> i amb el patrocini de Baxter<\/strong><\/a>, B. Braun<\/strong><\/a>, Persan Farma<\/strong><\/a> i Vegenat<\/strong><\/a>. <\/p>\n\n\n\n

\"Exterior<\/a>
Exterior de l’aula de formaci\u00f3 sobre \u201cActuaci\u00f3 farmac\u00e8utica en la nutrici\u00f3 artificial\u201d.<\/figcaption><\/figure>\n\n\n\n

La formaci\u00f3 va ser impartida per cinc farmac\u00e8utics<\/strong> adjunts<\/strong> de diferents centres hospitalaris: Montserrat Colls<\/strong> de l\u2019Hospital Universitari de Bellvitge, Elisabet Leiva<\/strong> de l\u2019Hospital Universitari de Bellvitge, Eduardo Clot<\/strong> de l\u2019Hospital de neurorehabilitaci\u00f3 de l\u2019Institut Guttmann, Miquel Villaronga<\/strong> de l\u2019Hospital Sant Joan de D\u00e9u, Jan Thomas De Pourcq<\/strong> de l\u2019Hospital de la Santa Creu i Sant Pau i Mar\u00eda Nevot<\/strong> de l\u2019Hospital Universitari Arnau de Vilanova. Un any m\u00e9s, el Grup de Nutrici\u00f3 de Farmac\u00e8utics d\u2019Hospitals de Catalunya <\/strong>va coordinar les jornades dirigides als farmac\u00e8utics hospitalaris.<\/p>\n\n\n\n

Els objectius<\/strong> de la formaci\u00f3 van ser ampliar els coneixements <\/strong>dels farmac\u00e8utics i proporcionar habilitats per fer intervencions farmac\u00e8utiques<\/strong> a l\u2019hora de tractar pacients sotmesos a nutrici\u00f3 artificial. Per fer-ho, es van realitzar tres jornades els dies 23, 25 i 30 de gener.<\/p>\n\n\n\n

Requisits de micronutrients en nutrici\u00f3 cl\u00ednica<\/strong><\/h2>\n\n\n\n

La primera jornada es va centrar, en primer lloc, en els requisits de micronutrients en nutrici\u00f3 cl\u00ednica<\/strong>. La farmac\u00e8utica adjunta de l\u2019Hospital Universitari de Bellvitge, Montserrat Colls<\/strong>, va comentar quines s\u00f3n les caracter\u00edstiques i els requisits <\/strong>dels micronutrients: que engloben les vitamines<\/strong>, les hidrosolubles i les liposolubles, i dels oligoelements<\/strong>. La farmac\u00e8utica va ressaltar \u201cque \u00e9s molt important la ingesta adequada dels micronutrients<\/strong>, en petites quantitats per assegurar el correcte funcionament de l\u2019organisme<\/strong>\u201d, ja que tenen funcions molt importants en l\u2019organisme perqu\u00e8 \u201cactuen com a cofactors d\u2019enzims, coenzims, regulaci\u00f3 de la transcripci\u00f3 de l\u2019ADN i com a antioxidants<\/strong>\u201d. <\/p>\n\n\n\n

\"La<\/a>
La farmac\u00e8utica, Montserrat Colls, durant la seva pon\u00e8ncia.<\/figcaption><\/figure>\n\n\n\n

Tamb\u00e9 va explicar quin \u00e9s el tractament<\/strong> si es produeix una defici\u00e8ncia, quins f\u00e0rmacs<\/strong> poden estar associats, els pacients que poden tenir risc <\/strong>de d\u00e8ficit, que poden ser pacients cr\u00edtics i amb altres tipus de patologies. Durant la pon\u00e8ncia tamb\u00e9 va parlar sobre la nutrici\u00f3 enteral i parenteral, la s\u00edndrome de refeeding<\/em>, la inflaci\u00f3 i com afecta en els micronutrients i va compartir alguns problemes que es troben en la pr\u00e0ctica di\u00e0ria.<\/p>\n\n\n\n

C\u00e0lcul de requisits nutricionals en pesos extrems<\/strong><\/h2>\n\n\n\n

En segon lloc, els farmac\u00e8utics hospitalaris van formar-se en el c\u00e0lcul de requisits nutricionals en pesos extrems<\/strong>. La farmac\u00e8utica adjunta de l\u2019Hospital Universitari de Bellvitge, Elisabet Leiva<\/strong>, va detallar l\u2019esquema general sobre la composici\u00f3 corporal<\/strong>. <\/p>\n\n\n\n

\"Elisabet<\/a>
Elisabet Leiva durant la seva intervenci\u00f3 sobre el c\u00e0lcul de requisits nutricionals en pesos extrems. <\/figcaption><\/figure>\n\n\n\n

Va recalcar la import\u00e0ncia de la valoraci\u00f3 nutricional<\/strong>, que \u201cens proporcionar\u00e0 informaci\u00f3 sobre l\u2019estat nutricional i la capacitat funcional que t\u00e9 el cos hum\u00e0, que \u00e9s molt rellevant en els pacients amb pesos molt extrems\u201d. A banda, la farmac\u00e8utica va centrar la seva exposici\u00f3 en el pacient ob\u00e8s<\/strong> i en el pacient amb baix pes<\/strong>.<\/p>\n\n\n\n

Nutrici\u00f3 en el pacient neurol\u00f2gic<\/strong><\/h2>\n\n\n\n

El farmac\u00e8utic adjunt de l\u2019Hospital de neurorehabilitaci\u00f3 de l\u2019Institut Guttmann, Eduardo Clot<\/strong>, va iniciar la segona jornada exposant quin \u00e9s el paper de la nutrici\u00f3 en el pacient neurol\u00f2gic<\/strong>. Clot va comentar que \u201cen pensar en nutrici\u00f3 cl\u00ednica o artificial, sovint oblidem el pacient neurol\u00f2gic, que t\u00e9 unes caracter\u00edstiques pr\u00f2pies i diferencials<\/strong> que cal tenir en compte en l\u2019abordatge nutricional\u201d. <\/p>\n\n\n\n

\"Eduardo<\/a>
Eduardo Clot en la seva exposici\u00f3 sobre la nutrici\u00f3 en el pacient neurol\u00f2gic. <\/figcaption><\/figure>\n\n\n\n

El farmac\u00e8utic va destacar que \u201cel pacient neurol\u00f2gic \u00e9s un pacient que es consumeix r\u00e0pidament\u201d, que \u201csempre calen requisits superiors als que es calcularien mitjan\u00e7ant f\u00f3rmules predictives\u201d i que \u201cles diselectrolit\u00e8mies<\/strong>, especialment la hiponatr\u00e8mia<\/strong>, s\u00f3n<\/strong> freq\u00fcents<\/strong>\u201d.<\/p>\n\n\n\n

El paper de les dietes cetog\u00e8niques<\/strong><\/h2>\n\n\n\n

Seguidament, el ponent Miquel Villaronga<\/strong> de l\u2019Hospital Sant Joan de D\u00e9u va abordar el paper de les dietes cetog\u00e8niques<\/strong>, que es tracta d\u2019un tipus de \u201cdieta rica en greixos<\/strong>, pobre en hidrats de carboni<\/strong> i amb una m\u00ednima quantitat de prote\u00efnes<\/strong>\u201d. <\/p>\n\n\n\n

\"El<\/a>
El farmac\u00e8utic adjunt, Miquel Villaronga, iniciant la seva pon\u00e8ncia. <\/figcaption><\/figure>\n\n\n\n

El farmac\u00e8utic va resumir el paper que tenen aquestes dietes, aix\u00ed com l\u2019origen, les tipologies (DC cl\u00e0ssica, DC-MCT, Dieta Atkins modificada, Dieta baix \u00edndex gluc\u00e8mic), les indicacions, les contradiccions i una pr\u00e0ctica. Per acabar la seva pon\u00e8ncia va compartir amb els assistents un cas cl\u00ednic.<\/p>\n\n\n\n

Estabilitat, compatibilitat i altres consultes relacionades amb l\u2019elaboraci\u00f3 i administraci\u00f3 de la nutrici\u00f3 parenteral<\/strong><\/h2>\n\n\n\n

La tercera jornada de formaci\u00f3, la va iniciar el farmac\u00e8utic Jan Thomas De Pourcq<\/strong> que va parlar sobre l\u2019estabilitat, compatibilitat i altres consultes relacionades amb l\u2019elaboraci\u00f3 i administraci\u00f3 de la nutrici\u00f3 parenteral. <\/strong>De Pourcq va introduir la sessi\u00f3 explicant per qu\u00e8 \u00e9s important el paper del farmac\u00e8utic en la nutrici\u00f3 parenteral<\/strong>, que \u201c\u00e9s qui ha d\u2019assegurar que sigui segura, estable i compatible amb la medicaci\u00f3<\/strong> que s\u2019administri\u201d. I va afegir que \u201c\u00e9s d\u2019elevada complexitat<\/strong> perqu\u00e8 hi ha m\u00faltiples factors: els electr\u00f2lits, les emulsions lip\u00eddiques, la glucosa, els amino\u00e0cids, les vitamines, els oligoelements i tamb\u00e9 poden intervenir els f\u00e0rmacs\u201d. <\/p>\n\n\n\n

\"\"<\/a>
Jan Thomas De Pourcq durant la seva exposici\u00f3 sobre l\u2019estabilitat, compatibilitat i altres consultes relacionades amb l\u2019elaboraci\u00f3 i administraci\u00f3 de la nutrici\u00f3 parenteral.<\/figcaption><\/figure>\n\n\n\n

Al llarg de la seva pon\u00e8ncia, Jan Thomas va repassar els m\u00e8todes de determinaci\u00f3 d\u2019estabilitat, la influ\u00e8ncia dels macronutrients, dels micronutrients i dels factors externs, l\u2019administraci\u00f3 de la nutrici\u00f3 parenteral, la caducitat i la compatibilitat amb f\u00e0rmacs.<\/p>\n\n\n\n

Nutrici\u00f3 parenteral en l\u2019embar\u00e0s<\/strong><\/h2>\n\n\n\n

Per tancar la formaci\u00f3, la farmac\u00e8utica Maria Nevot <\/strong>es va centrar en la nutrici\u00f3 parenteral en l\u2019embar\u00e0s<\/strong>. Nevot va destacar la relaci\u00f3<\/strong> que hi ha entre la nutrici\u00f3 materna<\/strong> i l\u2019evoluci\u00f3 fetal<\/strong> i que la despesa cal\u00f2rica de l\u2019embar\u00e0s<\/strong> \u201cno es distribueix per igual al llarg del per\u00edode gestacional\u201d. <\/p>\n\n\n\n

\"La<\/a>
La farmac\u00e8utica, Maria Nevot, va abordar la nutrici\u00f3 parenteral en l’embar\u00e0s durant la tercera jornada. <\/figcaption><\/figure>\n\n\n\n

Durant la sessi\u00f3, va repassar les patologies <\/strong>que afecten en la ingesta i l\u2019absorci\u00f3 de nutrients<\/strong> que poden causar d\u00e8ficits i, finalment, va presentar un cas cl\u00ednic.<\/p>\n\n\n

\n\n\n

Formaci\u00f3 espec\u00edfica sobre nutrici\u00f3 artificial per a t\u00e8cnics de farm\u00e0cia hospital\u00e0ria<\/strong> <\/h2>\n\n\n\n

El passat 1 de febrer, el Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/strong>, conjuntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica<\/strong> (SCFC)<\/strong> i la coordinaci\u00f3 del Grup de Nutrici\u00f3 de Farmac\u00e8utics d\u2019Hospitals de Catalunya<\/strong>, <\/strong>van realitzar una formaci\u00f3 espec\u00edfica sobre \u201cNutrici\u00f3 artificial per a t\u00e8cnics de farm\u00e0cia hospital\u00e0ria\u201d. <\/strong>Els ponents encarregats de dur a terme la sessi\u00f3 van ser les farmac\u00e8utiques adjuntes Laura Val<\/strong>, de l\u2019Hospital Universitari General de Catalunya, i Ana Puebla<\/strong>, de l\u2019Hospital de Sant Joan Desp\u00ed Mois\u00e8s Broggi.<\/p>\n\n\n\n

Els objectius<\/strong> de la formaci\u00f3 van ser habilitar els participants en els aspectes cl\u00ednics de la nutrici\u00f3 parenteral en nounats<\/strong> i els protocols de preparaci\u00f3<\/strong> i entendre els conceptes b\u00e0sics de la nutrici\u00f3 enteral<\/strong>.<\/p>\n\n\n\n

\"A<\/a>
A l’esquerra: la farmac\u00e8utica, Laura Val. A la dreta: la farmac\u00e8utica, Ana Puebla. <\/figcaption><\/figure>\n\n\n\n

La farmac\u00e8utica hospital\u00e0ria, Laura Val<\/strong>, va iniciar la seva pon\u00e8ncia introduint alguns conceptes b\u00e0sics de classificaci\u00f3 dels nadons <\/strong>segons si s\u00f3n nounats, l\u2019edat gestacional o el pes. Val va especificar que \u00e9s indicat administrar nutrici\u00f3 parenteral en nadons prematurs (RNPT) \u201cen vies metab\u00f2liques immadures, en demandes nutricionals incrementades, en estats m\u00e8dics\/quir\u00fargiques que alterin els requisits i l\u2019absorci\u00f3 de nutrients i en reserves nutricionals limitades\u201d. A m\u00e9s a m\u00e9s, la farmac\u00e8utica va repassar l\u2019acc\u00e9s vascular per administrar nutrici\u00f3 parenteral, la composici\u00f3 d\u2019aquest tipus de nutrici\u00f3 i les complicacions.<\/p>\n\n\n\n

\"Material<\/a>
Material d’administraci\u00f3 de nutrici\u00f3 artificial a l’exterior de l’aula de formaci\u00f3. <\/figcaption><\/figure>\n\n\n\n

La segona part de la formaci\u00f3 va anar a c\u00e0rrec de la farmac\u00e8utica, Ana Puebla<\/strong>, que va exposar els conceptes b\u00e0sics de la nutrici\u00f3 enteral<\/strong>, que s\u2019administra via digestiva, i que t\u00e9 alguns avantatges respecte a la parenteral<\/strong>: \u201c\u00e9s m\u00e9s fisiol\u00f2gica i senzilla, t\u00e9 menys complicacions i de menys gravetat, s\u2019eviten els efectes secundaris a la falta d\u2019utilitzaci\u00f3 de l\u2019aparell gastrointestinal, ofereix m\u00e9s autonomia i el cost \u00e9s m\u00e9s baix\u201d. Puebla va detallar les vies d\u2019acc\u00e9s al tracte digestiu, les f\u00f3rmules de nutrici\u00f3 enteral que existeixen i les dosis a pautar, els m\u00e8todes d\u2019administraci\u00f3 a utilitzar i les complicacions que poden derivar-se.<\/p><\/div>\n\n\n\n

Activitats coordinades per:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

Activitats organitzades conjuntament amb:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

Amb el patrocini de:<\/strong><\/p>\n\n\n\n

\n
\n
\"\"<\/a><\/figure>\n<\/div>\n\n\n\n
\n
\"\"<\/a><\/figure>\n<\/div>\n\n\n\n
\n
\"\"<\/a><\/figure>\n<\/div>\n\n\n\n
\n
\"\"<\/a><\/figure>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

A finals de gener, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar la XVII edici\u00f3 de la formaci\u00f3 \u201cActuaci\u00f3 farmac\u00e8utica en la nutrici\u00f3 artificial\u201d, conjuntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC), la coordinaci\u00f3 del Grup de Nutrici\u00f3 de Farmac\u00e8utics d\u2019Hospitals de Catalunya i amb el patrocini de […]<\/p>\n","protected":false},"author":1,"featured_media":67745,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[120,18,19,121,53,122,68,54,70,123,124,46,125,126,127,128,129],"class_list":["post-66134","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-actuacio-farmaceutica-en-nutricio-artificial","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-dieta-cetogenica","tag-farmaceutics","tag-farmaceutics-hospitalaris","tag-farmacia","tag-farmacs","tag-formacio","tag-micronutricio","tag-micronutrients","tag-nutricio","tag-nutricio-artificial","tag-nutricio-clinica","tag-nutricio-parenteral","tag-pacient-neurologic","tag-societat-catalana-de-farmacia-clinica-scfc"],"yoast_head":"\nNoves formacions en l'actuaci\u00f3 farmac\u00e8utica en pacients amb nutrici\u00f3 artificial - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"A finals de gener, el COFB va organitzar la XVII edici\u00f3 de la formaci\u00f3 \u201cActuaci\u00f3 farmac\u00e8utica en la nutrici\u00f3 artificial\u201d\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Noves formacions en l'actuaci\u00f3 farmac\u00e8utica en pacients amb nutrici\u00f3 artificial - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"A finals de gener, el COFB va organitzar la XVII edici\u00f3 de la formaci\u00f3 \u201cActuaci\u00f3 farmac\u00e8utica en la nutrici\u00f3 artificial\u201d\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-10T13:47:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-09T10:42:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Noves formacions en l’actuaci\u00f3 farmac\u00e8utica en pacients amb nutrici\u00f3 artificial\",\"datePublished\":\"2023-02-10T13:47:03+00:00\",\"dateModified\":\"2023-10-09T10:42:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/\"},\"wordCount\":1524,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1.jpg\",\"keywords\":[\"Actuaci\u00f3 farmac\u00e8utica en nutrici\u00f3 artificial\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"dieta cetog\u00e8nica\",\"farmac\u00e8utics\",\"farmac\u00e8utics hospitalaris\",\"Farm\u00e0cia\",\"f\u00e0rmacs\",\"Formaci\u00f3\",\"micronutrici\u00f3\",\"micronutrients\",\"Nutrici\u00f3\",\"nutrici\u00f3 artificial\",\"nutrici\u00f3 cl\u00ednica\",\"nutrici\u00f3 parenteral\",\"pacient neurol\u00f2gic\",\"Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC)\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/\",\"name\":\"Noves formacions en l'actuaci\u00f3 farmac\u00e8utica en pacients amb nutrici\u00f3 artificial - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1.jpg\",\"datePublished\":\"2023-02-10T13:47:03+00:00\",\"dateModified\":\"2023-10-09T10:42:05+00:00\",\"description\":\"A finals de gener, el COFB va organitzar la XVII edici\u00f3 de la formaci\u00f3 \u201cActuaci\u00f3 farmac\u00e8utica en la nutrici\u00f3 artificial\u201d\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1.jpg\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Noves formacions en l’actuaci\u00f3 farmac\u00e8utica en pacients amb nutrici\u00f3 artificial\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Noves formacions en l'actuaci\u00f3 farmac\u00e8utica en pacients amb nutrici\u00f3 artificial - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"A finals de gener, el COFB va organitzar la XVII edici\u00f3 de la formaci\u00f3 \u201cActuaci\u00f3 farmac\u00e8utica en la nutrici\u00f3 artificial\u201d","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/","og_locale":"ca_ES","og_type":"article","og_title":"Noves formacions en l'actuaci\u00f3 farmac\u00e8utica en pacients amb nutrici\u00f3 artificial - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"A finals de gener, el COFB va organitzar la XVII edici\u00f3 de la formaci\u00f3 \u201cActuaci\u00f3 farmac\u00e8utica en la nutrici\u00f3 artificial\u201d","og_url":"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2023-02-10T13:47:03+00:00","article_modified_time":"2023-10-09T10:42:05+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1.jpg","type":"image\/jpeg"}],"author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"9 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Noves formacions en l’actuaci\u00f3 farmac\u00e8utica en pacients amb nutrici\u00f3 artificial","datePublished":"2023-02-10T13:47:03+00:00","dateModified":"2023-10-09T10:42:05+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/"},"wordCount":1524,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1.jpg","keywords":["Actuaci\u00f3 farmac\u00e8utica en nutrici\u00f3 artificial","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","dieta cetog\u00e8nica","farmac\u00e8utics","farmac\u00e8utics hospitalaris","Farm\u00e0cia","f\u00e0rmacs","Formaci\u00f3","micronutrici\u00f3","micronutrients","Nutrici\u00f3","nutrici\u00f3 artificial","nutrici\u00f3 cl\u00ednica","nutrici\u00f3 parenteral","pacient neurol\u00f2gic","Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC)"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/","url":"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/","name":"Noves formacions en l'actuaci\u00f3 farmac\u00e8utica en pacients amb nutrici\u00f3 artificial - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1.jpg","datePublished":"2023-02-10T13:47:03+00:00","dateModified":"2023-10-09T10:42:05+00:00","description":"A finals de gener, el COFB va organitzar la XVII edici\u00f3 de la formaci\u00f3 \u201cActuaci\u00f3 farmac\u00e8utica en la nutrici\u00f3 artificial\u201d","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1.jpg","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2023\/02\/10\/noves-formacions-en-lactuacio-farmaceutica-en-pacients-amb-nutricio-artificial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Noves formacions en l’actuaci\u00f3 farmac\u00e8utica en pacients amb nutrici\u00f3 artificial"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1.jpg",1024,576,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1-300x169.jpg",300,169,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1-768x432.jpg",768,432,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1.jpg",1024,576,false],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1.jpg",1024,576,false],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1.jpg",1024,576,false],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Nutricio-artificial_09022023_0_portada-1024x576-1.jpg",18,10,false]},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"A finals de gener, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar la XVII edici\u00f3 de la formaci\u00f3 \u201cActuaci\u00f3 farmac\u00e8utica en la nutrici\u00f3 artificial\u201d, conjuntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC), la coordinaci\u00f3 del Grup de Nutrici\u00f3 de Farmac\u00e8utics d\u2019Hospitals de Catalunya i amb el patrocini de […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/66134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=66134"}],"version-history":[{"count":6,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/66134\/revisions"}],"predecessor-version":[{"id":68968,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/66134\/revisions\/68968"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/67745"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=66134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=66134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=66134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}